Dr Sanne Lugthart
/content/dam/genesiscare/headshots/uk-doctor-headshots/Dr Sanne Lugthart.jpg

Dr Sanne Lugthart

Dr Sanne Lugthart
Sanne
Lugthart
MD, PhD, Consultant Haematologist

Languages spoken

English, Dutch, German

Expert in

Lymphoma, chronic leukaemia, anaemia

Overview

Centres

Bristol
Bristol
300 Park Avenue, Aztec West, Bristol, Gloucestershire, BS32 4SY, England, UK
51.541807689358095, -2.5709663094294277
/uk/our-centres/bristol
Gloucestershire

Dr Sanne Lugthart completed her general medicine and haematology training in Erasmus Medical Centre, Rotterdam, The Netherlands. She completed her PhD in leukaemia and won several research funding awards with her research work. She had the opportunity to work in St Jude Children’s Hospital, Cornell Medical College and University of Ulm. Dr Sanne Lugthart has many scientific publications in leukaemia that have been ground breaking for treatment changes.

Dr Sanne Lugthart is based in Bristol since 2018 and has specialised in lymphoma and leukaemia. She is a member of the National CAR-T Cell Panel and NIHR high grade lymphoma group. She treats high-risk and low-risk lymphoma patients.

Dr Sanne Lugthart has extensive experience with phase 2 and 3 clinical trials in lymphoma, chronic leukaemia and haemoglobinopathy.

 

Offering patients with haematological malignancy a treatment that is curative preferably without many complications is the main reason for me to practise medicine. The cutting edge science that is applied in haematology is unique and our patients benefit from this. I hope to help patients in their treatment journey and thereafter to support them in achieving their goals.

Career positions

Current position(s)
  • University Hospitals of Bristol and Weston NHS Foundation Trust

Qualifications

  • Fellow of the Royal College of Pathology
  • Fellow of the Royal College of Physicians
  • Member of the European Hematology Association
  • Member of the Dutch Hematology Society

Awards

  • Clinical Excellence Award NHS 2022
  • Senior research award American Association of Hematology 2012

Expertise and interests

  • High grade lymphoma
  • Chronic Lymphocytic Leukaemia
  • Haemoglobinopathies
  • Specialised in lymphoma and CLL, with extensive clinical trial experience in phase 2 and phase 3 trials

Publications

1. Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK. Kuhnl A, Roddie C, Kirkwood AA, Chaganti S, Norman J, Lugthart S, Osborne W, Gibb A, Gonzalez Arias C, Latif A, Uttenthal B, Seymour F, Jones C, Springell D, Brady JL, Illidge T, Stevens A, Alexander E, Hawley L, O'Rourke N, Bedi C, Prestwich R, Frew J, Burns D, O'Reilly M, Sanderson R, Sivabalasingham S, Mikhaeel NG. Br J Haematol. 2024 Aug;205(2):483-494. doi: 10.1111/bjh.19453. Epub 2024 Apr 9. PMID: 38594876

2. Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes. Bourlon C, Roddie C, Menne T, Norman J, O'Reilly M, Gibb A, Besley C, Chaganti S, Arias CG, Jones C, Dikair A, Allen S, Seymour F, Osborne W, Mathew A, Townsend W, Patten PEM, Thoulouli E, Abdulgawad A, Lugthart S, Sanderson R, Kirkwood AA, Kuhnl A. Haematologica. 2024 Aug 1;109(8):2716-2720. doi: 10.3324/haematol.2024.285010. PMID: 38572567 Free PMC article. No abstract available.

3. The acute pain crisis in sickle cell disease: What can be done to improve outcomes? Telfer P, Anie KA, Kotsiopoulou S, Aiken L, Hibbs S, Burt C, Stuart-Smith S, Lugthart S. Blood Rev. 2024 May;65:101194. doi: 10.1016/j.blre.2024.101194. Epub 2024 Mar 19. PMID: 38553339 Review.

4. An update review of new therapies in sickle cell disease: the prospects for drug combinations. Lugthart S, Ginete C, Kuona P, Brito M, Inusa BPD. Expert Opin Pharmacother. 2024 Feb;25(2):157-170. doi: 10.1080/14656566.2024.2317336. Epub 2024 Mar 4. PMID: 38344818 Review.

5. Detection of CAR-T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories. Johansson U, Gallagher K, Burgoyne V, Maus MV, Casey KS, Brini GG, Frigault MJ, Yam JY, Chavda N, Besley C, Lugthart S. Cytometry B Clin Cytom. 2021 Nov;100(6):622-631. doi: 10.1002/cyto.b.22005. Epub 2021 Apr 29. PMID: 33915021